Medical Director of the Haemophilia Treatment Programme and Professor of MedicineSt Michael's Hospital Haemophilia Treatment Centre, University of TorontoTortonto, Ontario, Canada
OC 02.4 - Long-Term Follow-Up of Participants in the Phase I/II Trial of Dirloctocogene Samoparvovec (SPK-8011): Durable FVIII Expression and Clinically Meaningful Reduction of Bleeding
Saturday, June 22, 202413:45 – 14:00 ICT
PB0547 - A Canadian Roundtable Discussion of the Peri-operative Use of Nonacog beta pegol (N9-GP) for Persons with Moderate to Severe Hemophilia B
Monday, June 24, 202413:45 – 14:45 ICT
